These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26725553)

  • 1. Therapeutic Potential of Mesenchymal Stem Cells for the Treatment of Airway Remodeling in Pulmonary Diseases.
    Nejad-Moghaddam A; Panahi Y; Abdollahpour Alitappeh M; Borna H; Shokrgozar MA; Ghanei M
    Iran J Allergy Asthma Immunol; 2015 Dec; 14(6):552-68. PubMed ID: 26725553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressive effect of compact bone-derived mesenchymal stem cells on chronic airway remodeling in murine model of asthma.
    Ogulur I; Gurhan G; Aksoy A; Duruksu G; Inci C; Filinte D; Kombak FE; Karaoz E; Akkoc T
    Int Immunopharmacol; 2014 May; 20(1):101-9. PubMed ID: 24613203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cell trials for pulmonary diseases.
    Antunes MA; Laffey JG; Pelosi P; Rocco PR
    J Cell Biochem; 2014 Jun; 115(6):1023-32. PubMed ID: 24515922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
    Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
    Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cell therapy in lung disorders: pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell.
    Inamdar AC; Inamdar AA
    Exp Lung Res; 2013 Oct; 39(8):315-27. PubMed ID: 23992090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells and inflammatory lung diseases.
    Iyer SS; Co C; Rojas M
    Panminerva Med; 2009 Mar; 51(1):5-16. PubMed ID: 19352305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders.
    Zhao S; Wehner R; Bornhäuser M; Wassmuth R; Bachmann M; Schmitz M
    Stem Cells Dev; 2010 May; 19(5):607-14. PubMed ID: 19824807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory effects of stem cells.
    Wada N; Gronthos S; Bartold PM
    Periodontol 2000; 2013 Oct; 63(1):198-216. PubMed ID: 23931061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of adipose tissue-derived mesenchymal stem cells by rapamycin in a murine model of acute graft-versus-host disease.
    Kim KW; Moon SJ; Park MJ; Kim BM; Kim EK; Lee SH; Lee EJ; Chung BH; Yang CW; Cho ML
    Stem Cell Res Ther; 2015 Oct; 6():202. PubMed ID: 26497134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
    Payne NL; Sun G; McDonald C; Layton D; Moussa L; Emerson-Webber A; Veron N; Siatskas C; Herszfeld D; Price J; Bernard CC
    Cell Transplant; 2013; 22(8):1409-25. PubMed ID: 23057962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.
    Yi T; Song SU
    Arch Pharm Res; 2012 Feb; 35(2):213-21. PubMed ID: 22370776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concise review: adult mesenchymal stromal cell therapy for inflammatory diseases: how well are we joining the dots?
    Griffin MD; Elliman SJ; Cahill E; English K; Ceredig R; Ritter T
    Stem Cells; 2013 Oct; 31(10):2033-41. PubMed ID: 23766124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunosuppressive properties of non-cultured dermal-derived mesenchymal stromal cells and the control of graft-versus-host disease.
    Gao L; Liu F; Tan L; Liu T; Chen Z; Shi C
    Biomaterials; 2014 Apr; 35(11):3582-8. PubMed ID: 24468404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell therapy approaches for lung diseases: current status.
    Sueblinvong V; Weiss DJ
    Curr Opin Pharmacol; 2009 Jun; 9(3):268-73. PubMed ID: 19349209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine.
    Caplan AI
    J Cell Physiol; 2007 Nov; 213(2):341-7. PubMed ID: 17620285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR7 guides migration of mesenchymal stem cell to secondary lymphoid organs: a novel approach to separate GvHD from GvL effect.
    Li H; Jiang Y; Jiang X; Guo X; Ning H; Li Y; Liao L; Yao H; Wang X; Liu Y; Zhang Y; Chen H; Mao N
    Stem Cells; 2014 Jul; 32(7):1890-903. PubMed ID: 24496849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypical and functional characterization of bone marrow mesenchymal stem cells in patients with chronic graft-versus-host disease.
    Wang B; Hu Y; Liu L; Hu K; Tie R; He Y; Fu S; Zhu N; Luo Y; Yu X; Huang H
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1020-8. PubMed ID: 25708216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats.
    Kitazawa Y; Li XK; Xie L; Zhu P; Kimura H; Takahara S
    Cell Transplant; 2012; 21(2-3):581-90. PubMed ID: 22793067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of pulmonary inflammation by mesenchymal cells.
    Alkhouri H; Poppinga WJ; Tania NP; Ammit A; Schuliga M
    Pulm Pharmacol Ther; 2014 Dec; 29(2):156-65. PubMed ID: 24657485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of allergic airway inflammation in a mouse model of asthma by exogenous mesenchymal stem cells.
    Ou-Yang HF; Huang Y; Hu XB; Wu CG
    Exp Biol Med (Maywood); 2011 Dec; 236(12):1461-7. PubMed ID: 22114062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.